Brief: Initiator Pharma Looking Forward To Proceed Phase 1 Trial

Initiator Pharma A/S

13/09/2018 07:11

Sept 13 (Reuters) - Initiator Pharma A/S  INIT.TE :
    * INITIATOR PHARMA LOOKING FORWARD TO PROCEED PHASE 1 TRIAL
    * CARDIOVASCULAR INCIDENT WAS OBSERVED IN ONE SUBJECT
    * HAS NOW COMPLETED FULL EXAMINATION OF INCIDENT, PLANS TO SUBMIT AMENDMENT TO CLINICAL
TRIAL
PROTOCOL
    * INTENTS TO CONTINUE PHASE 1 TRIAL FOR IPED2015 AND DOSE MORE SUBJECTS UPON APPROVAL BY
MEDICINES
& HEALTHCARE PRODUCTS REGULATORY AGENCY (MHRA) AND ETHICS COMMITTEE (EC)

Source text for Eikon:  ID:nWkr6fBr1Q 
Further company coverage:  INIT.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))